Menu

Contineum Therapeutics, Inc. CTNM

Full chart Compare
Set alert

Price alert · CTNM

All alert types
9.52 USD +0.71 (+8.06%)

At closeNov 6, 2026, 4:00 PM EST

9.52 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

8.59 Day range 9.79
6.73 52-week range 17.79
YTD
-16.71%
1 year
-13.53%

Revenue & Expenses

Revenue → Gross Profit: $50.00MGross Profit → Net Income: $3.15MGross Profit → Selling, General & Admin: $6.32MGross Profit → Research & Development: $27.60MGross Profit → Interest Expense: $208.00KGross Profit → Other Expenses: $12.27MGross Profit → Income Tax: $450.00KGross Profit$50.00MNet Income$3.15MSelling, General & Admin$6.32MResearch & Development$27.60MInterest Expense$208.00KOther Expenses$12.27MIncome Tax$450.00KRevenue$50.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CTNM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
-68.06M-50.89M16.08M-22.72M
-59.98M-42.26M3.15M-24.25M
-2.17-2.180.08-10.81
CTNM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
75.60M21.94M15.53M5.57M
276.64M212.85M130.39M50.64M
15.65M14.78M5.70M11.37M
8.25M6.26M572.00K5.85M
260.99M198.07M-67.94M-93.21M
CTNM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
-55.31M-32.84M19.35M-20.12M
-3.71M-69.74M-65.57M22.30M
112.69M109.00M56.18M-1.24M
-231.00K-494.00K-414.00K-118.00K
53.66M6.42M9.96M939.00K